Skip to content

A Study to find out effectiveness of Malli Chooranam for Excessive Sweating

A pilot study to explore the effectiveness of Siddha Formulation Malli Chooranam in the management of Primary Hyperhidrosis(Adhiviyarvai) - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057920
Enrollment
10
Registered
2023-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L748- Other eccrine sweat disorders

Interventions

Intervention1: Drug: Drug Name Malli Chooranam Ingredients Parangichakkai(Smilaxchina),Adhimadhuram(Glycyrrhiza glabra),Karunjeeragam(Nigellasativa),Seeragam(Cuminum

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults >18 years and <60 years both sex diagnosed with Hyperhidrosis with an HDSS(Hyperhidrosis Disease Severity Scale) score of greater than 2.

Exclusion criteria

Exclusion criteria: - Prior use of any other medication(s) or procedure(s) within the specified timeframe for the treatment of hyperhidrosis. - Thermolysis, sympathectomy or surgical procedures at any time in the past for the treatment of hyperhidrosis. - Use of Anticholinergic agents within 15 days of the Baseline Visit . - Any other condition, including psychiatric illness (depression and/or anxiety) - Patients diagnosed with Secondary Hyperhidrosis (Diabetes,Hyperthyroidism, Tumours) - End Stage renal disease and Liver disorders.

Design outcomes

Primary

MeasureTime frame
-This study will discover the therapeutic effectiveness of Siddha herbal formulation Malli Chooranam in Hyperhidrosis. -Outcome is assessed by comparing the Hyperhidrosis Disease Severity Scale before and after treatment.Timepoint: 49 days

Secondary

MeasureTime frame
-Assessed by comparing the answers of Quality of Life in Hyperhidrosis assessment questionnarie before and after treatment.Timepoint: 49 days

Countries

India

Contacts

Public ContactDr M Suguna

National Institute of Siddha

drsugu.26@gmail.com8220841424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026